MARKET WIRE NEWS
  1. Home
  2. Stock
  3. LPCN
  4. News
LPCN
Quote
Short
News
Articles
Message Board

Lipocine Inc. (NASDAQ : LPCN ) News

Lipocine Inc. (NASDAQ: LPCN) News Releases

LPCN News Releases
LPCN : NASDAQ
PR Newswire
Lipocine Announces Last Patient Last Visit in Pivotal Phase 3 Trial of LPCN 1154 for Postpartum Depression (PPD)
LPCN : NASDAQ
PR Newswire
Lipocine Announces Completion of Enrollment and Dosing in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)
LPCN : NASDAQ
GlobeNewswire
2026 Asset Growth: Why Federal Compliance Is the New Metric
LPCN : NASDAQ
PR Newswire
Lipocine Reports Encouraging Progress Post Second Interim Safety Review in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)
LPCN : NASDAQ
Baystreet
Biotech's New Edge: 5 Companies Mastering "How" We Dose
LPCN : NASDAQ
QM US Market Movers News
US Companies Moving the Markets, Morning edition
Fri, Jan 02, 2026 as of 10.00 am ET
LPCN : NASDAQ
QM US Market Movers News
US Companies Moving the Markets, Evening edition
Wed, Dec 31, 2025 as of 4:00 pm ET
LPCN : NASDAQ
IBN Spotlights
Lipocine Inc. (NASDAQ: LPCN) Rises Sharply in 12/29 Early Trading Session
LPCN : NASDAQ
PR Newswire
Lipocine's PPD Phase 3 Study (LPCN 1154) Hits 80% Enrollment Milestone
LPCN : NASDAQ
PR Newswire
Lipocine Highlights Promising Interim Safety Profile in Phase 3 Trial of LPCN 1154 in Postpartum Depression (PPD)

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.